1. 155 Prognostic value and therapeutic implications of pleural carcinosis and malignant pleural effusion in advanced epithelial ovarian cancer. (13th November 2020) Authors: Nasser, S; Fotopoulou, C; Richter, R; Kaulich, J; Braicu, E; Beteta, C; Olschewski, J; Babyeva, A; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. (13th November 2020) Authors: Lorusso, D; Colombo, N; Coleman, R; Randall, L; Duska, L; Xiang, Y; Hasegawa, K; Nogueira-Rodrigues, A; Cibula, D; Raza Mirza, M; You, B; Oaknin, A; Christiaens, M; Taskiran, C; Sehouli, J; Korach, J; Martin, C; Keefe, S; Puglisi, M; Pignata, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 24 UTERUS-11 STUDY: A randomized clinical trial on surgical staging versus ct-staging prior to primary chemoradiation in patients with FIGO2009 stages IIB-IVA cervical cancer. (18th September 2019) Authors: Marnitz-Schulze, S; Tsunoda, A; Martus, P; Vieira, MV; Affonso, R; Nunes, JS; Budach, V; Schneider, A; Hertel, H; Mustea, A; Sehouli, J; Plaikner, A; Ebert, A; Köhler, C Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 264TiPENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian cancer. (24th November 2019) Authors: Fujiwara, K; Vergote, I B; Sehouli, J; Salutari, V; Zola, P; Madry, R; Wenham, R M; Korach, J; Pautier, P; Cibula, D; Lheureux, S; Hasegawa, K; Kim, B-G; Lai, C-H; Gonzalez-Martinez, A; Liu, Q; Keefe, S M; Puglisi, M; Topuz, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 318 Impact of the SARS-CoV2 pandemic on the clinical and research management of patients with gynecological malignancies: an ongoing survey in the Pan-Arabian region. (13th November 2020) Authors: Nasser, S; Awad, S; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 358 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-ov50/GOG-329/INNOVATE-3. (13th November 2020) Authors: Vergote, I; Salutari, V; Cibula, D; Korach, J; Samartzis, EP; Sehouli, J; Fossati, R; Martin, AG; Tsibulak, I; Slomovitz, B; Coleman, R; Monk, B; Thaker, P; O'Malley, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 393 Long-term neurological side effects in long-term survivors with ovarian cancer. (13th November 2020) Authors: El Ouardi, N; Woopen, H; Huehnchen, P; Boehmerle, W; Leithner, C; Braicu, E; Endres, M; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 439 Primary symptoms in women with different histopathological subtypes of gynaecological sarcoma – results of a prospective intergroup registry for gynaecological sarcoma (REGSA – NOGGO RU1). (13th November 2020) Authors: Roser, E; Pietzner, K; Brucker, S; Harter, P; Zocholl, D; Gimpel, A; Kalder, M; Bossart, M; Strauß, H; Wimberger, P; Armbrust, R; Marth, C; Fehm, T; Jurcikova, P; Mustea, A; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 463 LVSI and Ki67 in prediction of lymph-node metastasis in primary low-grade ovarian cancer. (13th November 2020) Authors: Grabowski, J; Glajzer, J; Richter, R; Plett, H; Muallem, MZ; Braicu, EI; Taube, E; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 934OAlienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. (23rd October 2018) Authors: Ray-Coquard, I L; Harter, P; Lorusso, D; Dalban, C; Vergote, I B; Fujiwara, K; Gladieff, L; Lueck, H-J; Floquet, A; Lesoin, A F; Schnelzer, A; Pignata, S; Selle, F; Sehouli, J; Brocard, F; Mangili, G; Pautier, P; De Giorgi, U; Provansal, M; Heudel, P-E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗